Monal Sanghvi

The code prohibits any pharmaceutical company or its agent from providing personal benefit that would incentivise a healthcare professional to prescribe a particular drug.

The code prohibits any pharmaceutical company or its agent from providing personal benefit that would incentivise a healthcare professional to prescribe a particular drug.

The acquisition will expand Eris' presence in the India-branded sterile injectables market.

The insurer has quietly stopped renewing its popular and low-cost health plan in a possible regulatory breach, forcing policyholders to either switch to costlier options.

The Association of Healthcare Providers (India) has filed the intervention.

The Insurance Regulatory and Development Authority of India approved eight principle-based consolidated regulations for the insurance sector leading

The Insurance Regulatory and Development Authority of India has issued the final regulations pertaining to Bima Sugam—Insurance Electronic

Surrender value is the amount received by the policyholder on surrender of the policy without completing its full tenure. The new regulations will come into effect from April 1.

While regulations for setting up Bima Sugam have just been approved, the concept draft of the actual platform and its features are awaited.

Most insurance plans invest 20–25% of the amount in equity, Chugh explains.